Home › Idiopathic Thrombocytopenic Purpura › Oregon
Idiopathic Thrombocytopenic Purpura clinical trials in Oregon
4 studies for Idiopathic Thrombocytopenic Purpura are looking for participants at sites in Oregon.
Cities in Oregon
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Oregon Health & Science University, Portland
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Oregon Health & Science University, Portland
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06948318Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- Oregon Health & Science University, Portland
RecruitingPhase 1
Ages 18 to 85 · All sexes · Updated Jul 22, 2026 · NCT06371417Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
- Oregon Health and Sciences University, Portland
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jun 22, 2026 · NCT07007962From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.